<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font17 { font-size : 17; } .font18 { font-size : 18; } .font19 { font-size : 19; } .font25 { font-size : 25; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">and </span>
   <span class="font25">the </span>
   <span class="font19">with </span>
   <span class="font18">patients </span>
   <span class="font17">COVID- </span>
   <span class="font16">[]. </span>
   <span class="font15">vs. </span>
   <span class="font14">for </span>
   <span class="font13">that </span>
   <span class="font13">myocardial </span>
   <span class="font13">are </span>
   <span class="font12">acute </span>
   <span class="font12">severe </span>
   <span class="font12">may </span>
   <span class="font12">from </span>
   <span class="font12">have </span>
   <span class="font12">was </span>
   <span class="font12">{background </span>
   <span class="font12">respiratory </span>
   <span class="font12">which </span>
   <span class="font11">injury </span>
   <span class="font11">[,]. </span>
   <span class="font11">been </span>
   <span class="font11">disease </span>
   <span class="font11">al. </span>
   <span class="font11">coronavirus </span>
   <span class="font11">(.%) </span>
   <span class="font11">has </span>
   <span class="font11">margin </span>
   <span class="font11">viral </span>
   <span class="font11">The </span>
   <span class="font11">cardiac </span>
   <span class="font11">heart </span>
   <span class="font11">were </span>
   <span class="font11">{border-style </span>
   <span class="font11">CVD </span>
   <span class="font11">ACE </span>
   <span class="font11">Cardiovascular </span>
   <span class="font11">Disease </span>
   <span class="font11">associated </span>
   <span class="font11">increased </span>
   <span class="font11">infection </span>
   <span class="font11">px;} </span>
   <span class="font11">risk </span>
   <span class="font11">than </span>
   <span class="font11">#ffffff;} </span>
   <span class="font11">(%)% </span>
   <span class="font11">(.%).% </span>
   <span class="font11">SARS-CoV- </span>
   <span class="font11">can </span>
   <span class="font11">Patients </span>
   <span class="font11">(%) </span>
   <span class="font11">cardiovascular </span>
   <span class="font11">clinical </span>
   <span class="font11">including </span>
   <span class="font11">COVID-, </span>
   <span class="font11">SARS </span>
   <span class="font11">studies </span>
   <span class="font11">study </span>
   <span class="font11">syndrome </span>
   <span class="font11">those </span>
   <span class="font11">Heart </span>
   <span class="font11">cases </span>
   <span class="font11">common </span>
   <span class="font11">other </span>
   <span class="font11">reported </span>
   <span class="font10">cohort </span>
   <span class="font10">higher </span>
   <span class="font10">more </span>
   <span class="font10">this </span>
   <span class="font10">(.% </span>
   <span class="font10">(â€") </span>
   <span class="font10">ECMO </span>
   <span class="font10">However, </span>
   <span class="font10">but </span>
   <span class="font10">case </span>
   <span class="font10">due </span>
   <span class="font10">enzyme </span>
   <span class="font10">had </span>
   <span class="font10">RAAS </span>
   <span class="font10">With </span>
   <span class="font10">Wuhan, </span>
   <span class="font10">data </span>
   <span class="font10">failure </span>
   <span class="font10">influenza </span>
   <span class="font10">mortality </span>
   <span class="font10">potential </span>
   <span class="font10">pulmonary </span>
   <span class="font10">such </span>
   <span class="font10">(Lond. </span>
   <span class="font10">Coronavirus </span>
   <span class="font10">Engl. </span>
   <span class="font10">Engl.)./S-()- </span>
   <span class="font10">among </span>
   <span class="font10">evidence </span>
   <span class="font10">increase </span>
   <span class="font10">lung </span>
   <span class="font10">myocarditis </span>
   <span class="font10">online: </span>
   <span class="font10">pre-existing </span>
   <span class="font10">rate </span>
   <span class="font10">recent </span>
   <span class="font10">&amp;lt; </span>
   <span class="font10">(COVID-) </span>
   <span class="font10">April </span>
   <span class="font10">COVID-. </span>
   <span class="font10">China </span>
   <span class="font10">al.Clinical </span>
   <span class="font10">also </span>
   <span class="font10">cause </span>
   <span class="font10">demonstrated </span>
   <span class="font10">found </span>
   <span class="font10">most </span>
   <span class="font10">novel </span>
   <span class="font10">number </span>
   <span class="font10">observed </span>
   <span class="font10">patients, </span>
   <span class="font10">pneumonia </span>
   <span class="font10">px; </span>
   <span class="font10">underlying </span>
   <span class="font10">who </span>
   <span class="font10">{font-family </span>
   <span class="font10">.collab: </span>
   <span class="font10">ARDS </span>
   <span class="font10">Myocardial </span>
   <span class="font10">angiotensin </span>
   <span class="font10">angiotensin-converting </span>
   <span class="font10">available </span>
   <span class="font10">between </span>
   <span class="font10">care </span>
   <span class="font10">complications </span>
   <span class="font10">critical </span>
   <span class="font10">effects </span>
   <span class="font10">fatality </span>
   <span class="font10">font-size </span>
   <span class="font10">high </span>
   <span class="font10">hospitalized </span>
   <span class="font10">immune </span>
   <span class="font10">incidence </span>
   <span class="font10">inflammatory </span>
   <span class="font10">inhibitors </span>
   <span class="font10">levels </span>
   <span class="font10">not </span>
   <span class="font10">patient </span>
   <span class="font10">receptor </span>
   <span class="font10">retrospective </span>
   <span class="font10">similar </span>
   <span class="font10">treatment </span>
   <span class="font10">troponin </span>
   <span class="font10">without </span>
   <span class="font10">.), </span>
   <span class="font10">Acute </span>
   <span class="font10">CAD </span>
   <span class="font10">J../eurheartj/ehaa </span>
   <span class="font10">SARS-CoV </span>
   <span class="font10">This </span>
   <span class="font10">[,], </span>
   <span class="font10">activity </span>
   <span class="font10">admission </span>
   <span class="font10">adverse </span>
   <span class="font10">coagulopathy </span>
   <span class="font10">considered </span>
   <span class="font10">double; </span>
   <span class="font10">drug </span>
   <span class="font10">during </span>
   <span class="font10">elevated </span>
   <span class="font10">human </span>
   <span class="font10">inflammation </span>
   <span class="font10">oxygen </span>
   <span class="font10">present </span>
   <span class="font10">prevalence </span>
   <span class="font10">reports </span>
   <span class="font10">review </span>
   <span class="font10">role </span>
   <span class="font10">suggested </span>
   <span class="font10">system </span>
   <span class="font10">these </span>
   <span class="font10">ventricular </span>
   <span class="font10">virus </span>
   <span class="font10">(%), </span>
   <span class="font10">(.%), </span>
   <span class="font10">.%, </span>
   <span class="font10">Cardiac </span>
   <span class="font10">Clinical </span>
   <span class="font10">East </span>
   <span class="font10">Infect. </span>
   <span class="font10">MERS </span>
   <span class="font10">Middle </span>
   <span class="font10">Moreover, </span>
   <span class="font10">Risk </span>
   <span class="font10">[,,]. </span>
   <span class="font10">abnormalities </span>
   <span class="font10">after </span>
   <span class="font10">and/or </span>
   <span class="font10">animal </span>
   <span class="font10">asymptomatic </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">cell </span>
   <span class="font10">coronary </span>
   <span class="font10">critically </span>
   <span class="font10">cytokine </span>
   <span class="font10">described </span>
   <span class="font10">disorders </span>
   <span class="font10">distress </span>
   <span class="font10">early </span>
   <span class="font10">first </span>
   <span class="font10">hospitalization </span>
   <span class="font10">ill </span>
   <span class="font10">illness </span>
   <span class="font10">mainly </span>
   <span class="font10">median </span>
   <span class="font10">mild </span>
   <span class="font10">older </span>
   <span class="font10">only </span>
   <span class="font10">remains </span>
   <span class="font10">response </span>
   <span class="font10">severity </span>
   <span class="font10">solid; </span>
   <span class="font10">some </span>
   <span class="font10">suggesting </span>
   <span class="font10">survivors </span>
   <span class="font10">symptoms </span>
   <span class="font10">therapies </span>
   <span class="font10">there </span>
   <span class="font10">thrombotic </span>
   <span class="font10">used </span>
   <span class="font10">years </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">(.%)% </span>
   <span class="font10">.%), </span>
   <span class="font10">Although </span>
   <span class="font10">American </span>
   <span class="font10">Angiotensin </span>
   <span class="font10">Cardiol../jamacardio.. </span>
   <span class="font10">Characteristics </span>
   <span class="font10">China: </span>
   <span class="font10">College </span>
   <span class="font10">Health </span>
   <span class="font10">Hospitalized </span>
   <span class="font10">ICU </span>
   <span class="font10">Inhibitors </span>
   <span class="font10">Italy </span>
   <span class="font10">MERS-CoV </span>
   <span class="font10">Management </span>
   <span class="font10">Med../NEJMoa </span>
   <span class="font10">New </span>
   <span class="font10">Non-ICU </span>
   <span class="font10">Potential </span>
   <span class="font10">RNA </span>
   <span class="font10">Respiratory </span>
   <span class="font10">SARS-CoV, </span>
   <span class="font10">Several </span>
   <span class="font10">Severe </span>
   <span class="font10">Table </span>
   <span class="font10">VTE </span>
   <span class="font10">[]ICU </span>
   <span class="font10">al.A </span>
   <span class="font10">all </span>
   <span class="font10">another </span>
   <span class="font10">any </span>
   <span class="font10">arrhythmia </span>
   <span class="font10">based </span>
   <span class="font10">bold </span>
   <span class="font10">cardiomyopathy </span>
   <span class="font10">cases, </span>
   <span class="font10">compared </span>
   <span class="font10">control </span>
   <span class="font10">could </span>
   <span class="font10">courier; </span>
   <span class="font10">current </span>
   <span class="font10">days, </span>
   <span class="font10">death </span>
   <span class="font10">detected </span>
   <span class="font10">disease, </span>
   <span class="font10">dysfunction </span>
   <span class="font10">em; </span>
   <span class="font10">embolism </span>
   <span class="font10">entry </span>
   <span class="font10">expression </span>
   <span class="font10">features </span>
   <span class="font10">function </span>
   <span class="font10">indicated </span>
   <span class="font10">infarction </span>
   <span class="font10">infected </span>
   <span class="font10">infections </span>
   <span class="font10">inhibition </span>
   <span class="font10">initial </span>
   <span class="font10">injury, </span>
   <span class="font10">large </span>
   <span class="font10">likely </span>
   <span class="font10">mechanism </span>
   <span class="font10">meta-analysis </span>
   <span class="font10">monitoring </span>
   <span class="font10">nonsurvivors </span>
   <span class="font10">patients. </span>
   <span class="font10">previously </span>
   <span class="font10">protease </span>
   <span class="font10">protective </span>
   <span class="font10">pt;} </span>
   <span class="font10">recently, </span>
   <span class="font10">report </span>
   <span class="font10">serum </span>
   <span class="font10">significant </span>
   <span class="font10">small </span>
   <span class="font10">spread </span>
   <span class="font10">suggest </span>
   <span class="font10">systemic </span>
   <span class="font10">their </span>
   <span class="font10">various </span>
   <span class="font10">when </span>
   <span class="font10">whether </span>
  </p>
 </body>
</html>
